{
    "root": "316a5f06-1f9b-7edc-e063-6394a90abbe9",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Ranolazine",
    "value": "20250328",
    "ingredients": [
        {
            "name": "HYPROMELLOSE 2910 (6 MPA.S)",
            "code": "0WZ8WG20P6",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17716"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A",
            "code": "NX76LV5T8J",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_25219"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14158"
        },
        {
            "name": "POLYETHYLENE GLYCOL 3350",
            "code": "G2M7P15E5P",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "POLYSORBATE 80",
            "code": "6OZP39ZG8H",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_53426"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_16189"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "TRIACETIN",
            "code": "XHX3C3X673",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_9661"
        },
        {
            "name": "SODIUM HYDROXIDE",
            "code": "55X04QC32I",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32145"
        },
        {
            "name": "FD&C YELLOW NO. 6",
            "code": "H77VEI93A8"
        },
        {
            "name": "RANOLAZINE",
            "code": "A6IEZ5M406",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_87681"
        },
        {
            "name": "HYPROMELLOSE 2910 (5 MPA.S)",
            "code": "R75537T0T4",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50819"
        },
        {
            "name": "FERRIC OXIDE RED",
            "code": "1K09F3G675",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50819"
        }
    ],
    "indications": {
        "text": "ranolazine extended-release tablets indicated treatment chronic angina . ranolazine extended-release tablets may used beta-blockers , nitrates , calcium channel blockers , anti-platelet therapy , lipid-lowering therapy , ace inhibitors , angiotensin receptor blockers .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "500 mg twice daily increase 1000 mg twice daily , based symptoms ( 2.1 )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "ranolazine extended release tablets supplied film-coated , oblong-shaped , extended-release tablets following strengths : 500 mg tablets orange , one side debossed s246 plain side 1000 mg tablets yellow , one side debossed s247 plain side ranolazine extended-release tablets available : strentgh ndc unit-of-use bottle ( 60 tablets ) 500 mg 70625-206-01 bottle ( 500 tablets ) 500 mg 70625-206-02 unit-of-use bottle ( 60 tablets ) 1000 mg 70625-207-01 bottle ( 500 tablets ) 1000 mg 70625-207-02 store 25\u00b0c ( 77\u00b0f ) ; excursions permitted 15\u00b0c 30\u00b0c ( 59\u00b0f 86\u00b0f ) . [ usp controlled room temperature . ] bottles 500 tablets household .",
    "adverseReactions": "ranolazine extended-release tablets contraindicated patients : taking strong inhibitors cyp3a [ ( 7.1 ) ] taking inducers cyp3a [ ( 7.1 ) ] liver cirrhosis [ ( 8.6 ) ]",
    "indications_original": "Ranolazine extended-release tablets are indicated for the treatment of chronic angina.\n                  Ranolazine extended-release tablets may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, ACE inhibitors, and angiotensin receptor blockers.",
    "contraindications_original": "500 mg twice daily and increase to 1000 mg twice daily, based on clinical symptoms (2.1)",
    "warningsAndPrecautions_original": "Ranolazine Extended Release Tablets are supplied as film-coated, oblong-shaped, extended-release tablets in the following strengths:\n                  \n                     500 mg tablets are orange, with one side debossed S246 and plain on the other side\n                     1000 mg tablets are yellow, with one side debossed S247 and plain on the other side\n                  \n                  Ranolazine extended-release tablets are available in:\n                  \n                     \n                     \n                        \n                           \n                           \n                              \n                                 Strentgh\n                              \n                           \n                           \n                              \n                                 NDC\n                              \n                           \n                        \n                        \n                           \u00a0Unit-of-Use Bottle (60 Tablets)\n                           \u00a0500 mg\n                           \u00a070625-206-01\n                        \n                        \n                           \u00a0Bottle (500 Tablets)\n                           \u00a0500 mg\n                           \u00a070625-206-02\n                        \n                        \n                           \u00a0Unit-of-Use Bottle (60 Tablets)\n                           \u00a01000 mg\n                           \u00a070625-207-01\n                        \n                        \n                           \u00a0Bottle (500 Tablets)\n                           \u00a01000 mg\n                           \u00a070625-207-02\n                        \n                     \n                  \n                  Store at 25\u00b0C (77\u00b0F); with excursions permitted to 15\u00b0C to 30\u00b0C (59\u00b0F to 86\u00b0F). [See USP Controlled Room Temperature.]\n                  Bottles of 500 tablets are not for household use.",
    "adverseReactions_original": "Ranolazine extended-release tablets are contraindicated in patients:\n                  \n                     Taking strong inhibitors of CYP3A \n        \n  \n   [see \n                        Drug Interactions (7.1)\n                        ]\n                     \n                     Taking inducers of CYP3A \n        \n  \n   [see \n                        Drug Interactions (7.1)\n                        ]\n                     \n                     With liver cirrhosis \n        \n  \n   [see \n                        Use in Specific Populations (8.6)\n                        ]",
    "drug": [
        {
            "name": "Ranolazine",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_87681"
        }
    ]
}